Zepbound is a dual GIP and GLP-1 receptor agonist, which means it activates both incretin pathways to enhance blood sugar control and support effective, long-term weight loss
While the standard regimen is a weekly injection, the exact frequency can be adjusted based on individual progress and any side effects experienced
Some serious risks include hypoglycemia, thyroid tumors, altered immune responses, and gallbladder disease
Once the shortage ended, the FDA made it clear that these clones are no longer allowed, Dr
Marginal structural models were used to evaluate the association between GLP-1RAs and MACE risk, accounting for time-varying confounding using inverse probability weighting, although residual confounding cannot be fully excluded
Patients could spend six months to a year or longer in the weight care vertical, depending on their needs